NASDAQ:DCGO DocGo (DCGO) Stock Price, News & Analysis → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free DCGO Stock Alerts $3.23 +0.03 (+0.94%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$3.07▼$3.2450-Day Range$2.87▼$3.8552-Week Range$2.78▼$10.82Volume813,686 shsAverage Volume1.36 million shsMarket Capitalization$328.07 millionP/E Ratio16.15Dividend YieldN/APrice Target$7.75 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get DocGo alerts: Email Address DocGo MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside139.9% Upside$7.75 Price TargetShort InterestBearish9.74% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.34Based on 4 Articles This WeekInsider TradingAcquiring Shares$146,150 Bought Last QuarterProj. Earnings Growth-50.00%From $0.24 to $0.12 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.24 out of 5 starsMedical Sector295th out of 905 stocksHealth Services Industry3rd out of 10 stocks 4.5 Analyst's Opinion Consensus RatingDocGo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageDocGo has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about DocGo's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted9.74% of the float of DocGo has been sold short.Short Interest Ratio / Days to CoverDocGo has a short interest ratio ("days to cover") of 7.8.Change versus previous monthShort interest in DocGo has recently decreased by 4.26%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldDocGo does not currently pay a dividend.Dividend GrowthDocGo does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DCGO. Previous Next 1.9 News and Social Media Coverage News SentimentDocGo has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for DocGo this week, compared to 4 articles on an average week.MarketBeat Follows6 people have added DocGo to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, DocGo insiders have bought more of their company's stock than they have sold. Specifically, they have bought $146,150.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of DocGo is held by insiders.Percentage Held by Institutions56.44% of the stock of DocGo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DocGo's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for DocGo are expected to decrease by -50.00% in the coming year, from $0.24 to $0.12 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DocGo is 16.15, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.36.Price to Earnings Ratio vs. SectorThe P/E ratio of DocGo is 16.15, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 139.42.Price to Earnings Growth RatioDocGo has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDocGo has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about DocGo's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Weiss RatingsWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.” About DocGo Stock (NASDAQ:DCGO)DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.Read More DCGO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DCGO Stock News HeadlinesMay 14, 2024 | insidertrades.comDocGo Inc. (NASDAQ:DCGO) General Counsel Purchases $31,300.00 in StockJune 11 at 2:16 AM | americanbankingnews.comDocGo Inc. (NASDAQ:DCGO) Receives $7.75 Average Target Price from AnalystsMay 21, 2024 | businesswire.comDocGo Announces Upcoming Participation at Stifel Cross Sector Insight ConferenceMay 12, 2024 | finance.yahoo.comDocGo Inc. (NASDAQ:DCGO) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comDocGo Inc (DCGO) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 PerformanceMay 10, 2024 | finance.yahoo.comDocGo First Quarter 2024 Earnings: EPS Beats ExpectationsMay 9, 2024 | markets.businessinsider.comBuy Rating on DocGo: Strong Growth Potential and Financial Health Despite Revenue Base ChangesMay 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: DocGo (DCGO), Avadel Pharmaceuticals (AVDL)May 9, 2024 | finance.yahoo.comDocGo Inc (DCGO) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and Strategic ...May 8, 2024 | investorplace.comDCGO Stock Earnings: DocGo Beats EPS, Beats Revenue for Q1 2024May 8, 2024 | finance.yahoo.comDocGo Announces Strong First Quarter 2024 ResultsMay 8, 2024 | finance.yahoo.comWith 52% ownership of the shares, DocGo Inc. (NASDAQ:DCGO) is heavily dominated by institutional ownersMay 1, 2024 | nasdaq.comDocGo Inc. Common Stock (DCGO)April 30, 2024 | markets.businessinsider.comEvaluating DocGo: Insights From 8 Financial AnalystsApril 22, 2024 | businesswire.comDocGo to Announce First Quarter 2024 Results on Wednesday, May 8, 2024April 17, 2024 | msn.comDocGo (DCGO) Price Target Decreased by 7.98% to 10.08April 12, 2024 | investing.comStifel cuts DocGo stock target, maintains buy amid contract shiftApril 11, 2024 | markets.businessinsider.comPeeling Back The Layers: Exploring DocGo Through Analyst InsightsApril 10, 2024 | businesswire.comDocGo Signs Extension and Begins Planned Transition of Asylum Seeker Contract with New York City HPDApril 10, 2024 | msn.comDocGo slips as New York City moves to end migrant contractApril 2, 2024 | businesswire.comDocGo Becomes Official Partner of New York City Football ClubMarch 29, 2024 | businesswire.comDOCGO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DocGo Inc. - DCGOMarch 28, 2024 | finance.yahoo.comDeclining Stock and Decent Financials: Is The Market Wrong About DocGo Inc. (NASDAQ:DCGO)?March 20, 2024 | markets.businessinsider.comDocGo Inc. (DCGO) Investor Alert: Grabar Law Office Investigates Claims on Behalf Of DocGo InvestorsMarch 20, 2024 | investing.comDocGo CFO Norman Rosenberg buys $36.1k in company sharesSee More Headlines Receive DCGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DocGo and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today6/11/2024Next Earnings (Estimated)8/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryN/A Current SymbolNASDAQ:DCGO CUSIPN/A CIK1822359 Webwww.docgo.com Phone844-443-6246FaxN/AEmployees4,164Year FoundedN/APrice Target and Rating Average Stock Price Target$7.75 High Stock Price Target$16.00 Low Stock Price Target$5.00 Potential Upside/Downside+139.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.20 Trailing P/E Ratio16.15 Forward P/E Ratio13.46 P/E Growth1.55Net Income$6.86 million Net Margins2.98% Pretax Margin5.41% Return on Equity6.20% Return on Assets4.14% Debt Debt-to-Equity RatioN/A Current Ratio2.09 Quick Ratio2.09 Sales & Book Value Annual Sales$624.29 million Price / Sales0.53 Cash Flow$0.22 per share Price / Cash Flow14.61 Book Value$2.93 per share Price / Book1.10Miscellaneous Outstanding Shares101,570,000Free Float98,824,000Market Cap$328.07 million OptionableOptionable Beta0.90 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Lee Bienstock (Age 39)CEO & Director Comp: $2.21MMr. Norman Rosenberg (Age 54)Treasurer & CFO Comp: $1.43MMr. Ely D. Tendler (Age 56)General Counsel, Secretary & Director Comp: $926.37kMr. Stephen Sugrue (Age 51)Chief Compliance Officer Comp: $864.35kMr. Andre Oberholzer CPA (Age 65)Executive Vice President of Strategy Comp: $1.48MMike ColeVice President of Investor RelationsMs. Rosemarie MilanoVice President of Human ResourcesMr. Aaron SeversChief Product OfficerMs. Vrenely MunozChief Revenue OfficerDr. James PowellChief Executive Officer of Clinical Practice GroupMore ExecutivesKey CompetitorsQuantum-SiNASDAQ:QSIOrigin MaterialsNASDAQ:ORGNAgroFresh SolutionsNASDAQ:AGFSLatchNASDAQ:LTCHThe Pennant GroupNASDAQ:PNTGView All CompetitorsInsiders & InstitutionsKennedy Capital Management LLCSold 314,520 shares on 5/16/2024Ownership: 1.418%Janus Henderson Group PLCSold 12,216 shares on 5/16/2024Ownership: 0.332%Jacobs Levy Equity Management Inc.Bought 166,247 shares on 5/16/2024Ownership: 0.160%California State Teachers Retirement SystemSold 4,146 shares on 5/16/2024Ownership: 0.084%Price T Rowe Associates Inc. MDBought 11,174 shares on 5/15/2024Ownership: 0.045%View All Insider TransactionsView All Institutional Transactions DCGO Stock Analysis - Frequently Asked Questions Should I buy or sell DocGo stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DocGo in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" DCGO shares. View DCGO analyst ratings or view top-rated stocks. What is DocGo's stock price target for 2024? 5 brokerages have issued 1-year price objectives for DocGo's stock. Their DCGO share price targets range from $5.00 to $16.00. On average, they expect the company's stock price to reach $7.75 in the next year. This suggests a possible upside of 139.9% from the stock's current price. View analysts price targets for DCGO or view top-rated stocks among Wall Street analysts. How have DCGO shares performed in 2024? DocGo's stock was trading at $5.59 at the beginning of 2024. Since then, DCGO stock has decreased by 42.2% and is now trading at $3.23. View the best growth stocks for 2024 here. When is DocGo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 5th 2024. View our DCGO earnings forecast. How were DocGo's earnings last quarter? DocGo Inc. (NASDAQ:DCGO) announced its quarterly earnings data on Wednesday, May, 8th. The company reported $0.09 EPS for the quarter, meeting analysts' consensus estimates of $0.09. The company earned $192.09 million during the quarter, compared to analysts' expectations of $185.36 million. DocGo had a net margin of 2.98% and a trailing twelve-month return on equity of 6.20%. What ETF holds DocGo's stock? Global X Telemedicine & Digital Health ETF holds 57,674 shares of DCGO stock, representing 0.37% of its portfolio. What guidance has DocGo issued on next quarter's earnings? DocGo issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600.0 million-$650.0 million, compared to the consensus revenue estimate of $714.3 million. Who are DocGo's major shareholders? DocGo's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (4.66%), WCM Investment Management LLC (2.52%), Kennedy Capital Management LLC (1.42%), Isthmus Partners LLC (0.58%), Pasadena Private Wealth LLC (0.38%) and Janus Henderson Group PLC (0.33%). Insiders that own company stock include Adriaan Stephanus Oberholzer, Anthony Capone, Ely D Tendler, James M Travers, Lee Bienstock, Michael J Burdiek and Stephen Sugrue. View institutional ownership trends. How do I buy shares of DocGo? Shares of DCGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DCGO) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredNVDA to close the AI “wealth window’ June 25?On Tuesday, June 25, in front of executives from nearly every major tech company in existence, key leaders at ...Paradigm Direct | Sponsored"If I Die, I’d Trust 50% of My Daughters’ Inheritance in ONE Stock.""I'd Feel Secure Putting 50% of My Kids' Inheritance in THIS Stock" One Wall Street millionaire bought AAPL...Stansberry Research | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.